Literature DB >> 8038944

Prevalence and associated features of epilepsy in adults with Down's syndrome.

R W McVicker1, O E Shanks, R J McClelland.   

Abstract

The aim of this study was to establish the prevalence of epilepsy in persons with Down's syndrome aged 19 years and over. A total of 191 adults with Down's syndrome were identified, giving a prevalence of 0.76/1000 (95% CI 0.75 to 0.77). Of these, 18 had epilepsy, giving a prevalence of 9.4% (95% CI 5.3% to 13.5%). The prevalence of epilepsy increased with age, reaching 46% in those over 50. The neurophysiological (EEG) findings of the epilepsy group were compared with those of a control group of Down's syndrome adults without epilepsy. Paroxysmal abnormalities consistent with a diagnosis of epilepsy were found in 80% of the epilepsy group, compared with only 13% of controls (P < 0.001). Epilepsy of late onset was associated with diffuse EEG abnormalities and clinical evidence of dementia. The age distribution and EEG findings suggest two independent processes in the causation of epilepsy: late-onset epilepsy associated with clinical evidence of dementia, and early-onset epilepsy in the absence of dementia.

Entities:  

Mesh:

Year:  1994        PMID: 8038944     DOI: 10.1192/bjp.164.4.528

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

3.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

4.  Progressive myoclonus epilepsy in Down syndrome patients with dementia.

Authors:  Giuseppe d'Orsi; Luigi M Specchio
Journal:  J Neurol       Date:  2014-06-04       Impact factor: 4.849

5.  Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability.

Authors:  Maria Alemany-González; Thomas Gener; Pau Nebot; Marta Vilademunt; Mara Dierssen; M Victoria Puig
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

6.  Characterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTB.

Authors:  Véronique Brault; Benoît Martin; Nathalie Costet; Jean-Charles Bizot; Yann Hérault
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

7.  Abnormal brain synchrony in Down Syndrome.

Authors:  Jeffrey S Anderson; Jared A Nielsen; Michael A Ferguson; Melissa C Burback; Elizabeth T Cox; Li Dai; Guido Gerig; Jamie O Edgin; Julie R Korenberg
Journal:  Neuroimage Clin       Date:  2013-05-24       Impact factor: 4.881

8.  Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome.

Authors:  Markus Heinen; Moritz M Hettich; Devon P Ryan; Susanne Schnell; Katharina Paesler; Dan Ehninger
Journal:  Neural Plast       Date:  2012-07-16       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.